190 related articles for article (PubMed ID: 30867782)
1. PABPC1L depletion inhibits proliferation and migration via blockage of AKT pathway in human colorectal cancer cells.
Wu YQ; Ju CL; Wang BJ; Wang RG
Oncol Lett; 2019 Mar; 17(3):3439-3445. PubMed ID: 30867782
[TBL] [Abstract][Full Text] [Related]
2. Activation of PI3K/AKT is involved in TINAG-mediated promotion of proliferation, invasion and migration of hepatocellular carcinoma.
Zhang MH; Niu H; Li Z; Huo RT; Wang JM; Liu J
Cancer Biomark; 2018; 23(1):33-43. PubMed ID: 29991125
[TBL] [Abstract][Full Text] [Related]
3. Interferon-induced transmembrane protein 2 is a prognostic marker in colorectal cancer and promotes its progression by activating the PI3K/AKT pathway.
Liu Y; Liang J; Li X; Huang J; Huang J; Wang J
Discov Oncol; 2024 May; 15(1):191. PubMed ID: 38802621
[TBL] [Abstract][Full Text] [Related]
4. Cancer Susceptibility Candidate 9 (CASC9) Promotes Colorectal Cancer Carcinogenesis via mTOR-Dependent Autophagy and Epithelial-Mesenchymal Transition Pathways.
Islam Khan MZ; Law HKW
Front Mol Biosci; 2021; 8():627022. PubMed ID: 34017854
[TBL] [Abstract][Full Text] [Related]
5. lncRNA KCNQ1OT1 knockdown inhibits colorectal cancer cell proliferation, migration and invasiveness via the PI3K/AKT pathway.
Duan Q; Cai L; Zheng K; Cui C; Huang R; Zheng Z; Xie L; Wu C; Yu X; Yu J
Oncol Lett; 2020 Jul; 20(1):601-610. PubMed ID: 32565985
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA-128 targeting RPN2 inhibits cell proliferation and migration through the Akt-p53-cyclin pathway in colorectal cancer cells.
Zhou T; Wu L; Wang Q; Jiang Z; Li Y; Ma N; Chen W; Hou Z; Gan W; Chen S
Oncol Lett; 2018 Dec; 16(6):6940-6949. PubMed ID: 30546426
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA-935 acts as a prognostic marker and promotes cell proliferation, migration, and invasion in colorectal cancer.
Huang Y; Xiao W; Jiang X; Li H
Cancer Biomark; 2019; 26(2):229-237. PubMed ID: 31524145
[TBL] [Abstract][Full Text] [Related]
8. IMPDH2 promotes colorectal cancer progression through activation of the PI3K/AKT/mTOR and PI3K/AKT/FOXO1 signaling pathways.
Duan S; Huang W; Liu X; Liu X; Chen N; Xu Q; Hu Y; Song W; Zhou J
J Exp Clin Cancer Res; 2018 Dec; 37(1):304. PubMed ID: 30518405
[TBL] [Abstract][Full Text] [Related]
9. Effect of long non-coding RNA Gas5 on proliferation, migration, invasion and apoptosis of colorectal cancer HT-29 cell line.
Li J; Wang Y; Zhang CG; Xiao HJ; Xiao HJ; Hu JM; Hou JM; He JD
Cancer Cell Int; 2018; 18():4. PubMed ID: 29308053
[TBL] [Abstract][Full Text] [Related]
10. Prognostic and predictive value of long non-coding RNA GAS5 and mircoRNA-221 in colorectal cancer and their effects on colorectal cancer cell proliferation, migration and invasion.
Liu L; Meng T; Yang XH; Sayim P; Lei C; Jin B; Ge L; Wang HJ
Cancer Biomark; 2018; 22(2):283-299. PubMed ID: 29630521
[TBL] [Abstract][Full Text] [Related]
11. Decreased expression of semaphorin 3D is associated with genesis and development in colorectal cancer.
Wang Z; Ding M; Qian N; Song B; Yu J; Tang J; Wang J
World J Surg Oncol; 2017 Mar; 15(1):67. PubMed ID: 28320475
[TBL] [Abstract][Full Text] [Related]
12. Effect of HOXA6 on the proliferation, apoptosis, migration and invasion of colorectal cancer cells.
Wu S; Wu F; Jiang Z
Int J Oncol; 2018 Jun; 52(6):2093-2100. PubMed ID: 29620285
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA-7 inhibits colorectal cancer cell proliferation, migration and invasion via TYRO3 and phosphoinositide 3-kinase/protein B kinase/mammalian target of rapamycin pathway suppression.
Qin A; Qian W
Int J Mol Med; 2018 Nov; 42(5):2503-2514. PubMed ID: 30226533
[TBL] [Abstract][Full Text] [Related]
14. LncRNA SNHG6 promotes proliferation, invasion and migration in colorectal cancer cells by activating TGF-β/Smad signaling pathway via targeting UPF1 and inducing EMT via regulation of ZEB1.
Wang X; Lai Q; He J; Li Q; Ding J; Lan Z; Gu C; Yan Q; Fang Y; Zhao X; Liu S
Int J Med Sci; 2019; 16(1):51-59. PubMed ID: 30662328
[No Abstract] [Full Text] [Related]
15. SULF1 regulates malignant progression of colorectal cancer by modulating ARSH via FAK/PI3K/AKT/mTOR signaling.
Zhu W; Wu C; Liu Z; Zhao S; Cheng X; Huang J
Cancer Cell Int; 2024 Jun; 24(1):201. PubMed ID: 38844922
[TBL] [Abstract][Full Text] [Related]
16. The high expression of long non-coding RNA PANDAR indicates a poor prognosis for colorectal cancer and promotes metastasis by EMT pathway.
Lu M; Liu Z; Li B; Wang G; Li D; Zhu Y
J Cancer Res Clin Oncol; 2017 Jan; 143(1):71-81. PubMed ID: 27629879
[TBL] [Abstract][Full Text] [Related]
17. Overexpression of HOXC10 promotes glioblastoma cell progression to a poor prognosis via the PI3K/AKT signalling pathway.
Guan Y; He Y; Lv S; Hou X; Li L; Song J
J Drug Target; 2019 Jan; 27(1):60-66. PubMed ID: 29768063
[TBL] [Abstract][Full Text] [Related]
18. Knockdown of CLDN6 inhibits cell proliferation and migration via PI3K/AKT/mTOR signaling pathway in endometrial carcinoma cell line HEC-1-B.
Cao X; He GZ
Onco Targets Ther; 2018; 11():6351-6360. PubMed ID: 30319275
[TBL] [Abstract][Full Text] [Related]
19. LncRNA AB073614 regulates proliferation and metastasis of colorectal cancer cells via the PI3K/AKT signaling pathway.
Wang Y; Kuang H; Xue J; Liao L; Yin F; Zhou X
Biomed Pharmacother; 2017 Sep; 93():1230-1237. PubMed ID: 28738539
[TBL] [Abstract][Full Text] [Related]
20. Bromodomain-containing protein 9 activates proliferation and epithelial-mesenchymal transition of colorectal cancer via the estrogen pathway
Chen P; Du R; Chang Z; Gao W; Zhao W; Dong G
J Gastrointest Oncol; 2023 Apr; 14(2):980-996. PubMed ID: 37201092
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
